MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647095421 A) filed by Cancer Research Technology Ltd; The Chancellor, Masters And Scholars Of The; and University College London on August 06, 2026, for Treatment And Prevention Of Lung Cancer.
Inventors include Litchfield, Kevin; Simpson, Benjamin Number; Swanton, Charles; Jamal-Hanjani, Mariam; Elliott, Timothy; and Blagden, Sarah.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: An immunogenic composition is described comprising a nucleic acid molecule encoding a plurality of antigens or cells presenting said plurality of antigens, wherein the antigens of said plurality of antigens are associated with mutations in at least two genes selected from TP53, KRAS and EGFR Related vectors, isolated nucleic acids and methods are described.
Disclaimer: Curated by HT Syndication.
